BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/26/2020 9:59:39 AM | Browse: 475 | Download: 792
Publication Name World Journal of Clinical Cases
Manuscript ID 57943
Country/Territory China
Received
2020-07-04 07:14
Peer-Review Started
2020-07-04 07:14
To Make the First Decision
Return for Revision
2020-07-24 03:15
Revised
2020-08-03 09:26
Second Decision
2020-09-02 12:25
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-09-03 02:34
Articles in Press
2020-09-03 02:34
Publication Fee Transferred
Edit the Manuscript by Language Editor
2020-09-17 02:10
Typeset the Manuscript
2020-10-12 04:33
Publish the Manuscript Online
2020-10-26 09:59
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Critical Care Medicine
Manuscript Type Retrospective Study
Article Title Predictive value of serum cystatin C for risk of mortality in severe and critically ill patients with COVID-19
Manuscript Source Invited Manuscript
All Author List Yan Li, Shuang Yang, Ding Peng, Hong-Ming Zhu, Bang-Yi Li, Xiaojiao Yang, Xue-Lian Sun and Mei Zhang
ORCID
Author(s) ORCID Number
Yan Li http://orcid.org/0000-0002-2340-1937
Shuang Yang http://orcid.org/0000-0003-0652-9266
Ding Peng http://orcid.org/0000-0003-3614-5538
Hong-Ming Zhu http://orcid.org/0000-0002-8596-177x
Bang-Yi Li http://orcid.org/0000-0002-5944-9641
Xiaojiao Yang http://orcid.org/0000-0003-3667-1239
Xue-Lian Sun http://orcid.org/0000-0003-3372-0410
Mei Zhang http://orcid.org/0000-0002-8596-1868
Funding Agency and Grant Number
Corresponding Author Mei Zhang, MD, Chief Physician, Professor, Department of Gastroenterology, Xuanwu Hospital of Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing 100053, China. zhang2955@sina.com
Key Words COVID-19; Cystatin C; Acute kidney injury; Renal function; Coronavirus infections; Multiple organ dysfunction syndrome
Core Tip The novel coronavirus epidemic has become a major public health event in the world. The mortality rate of severe and critical patients is high. It is very important to find an available, cheap, and sensitive biomarker to predict mortality. Cystatin C is a predictor of renal injury. We compared 101 severe and critical patients with coronavirus disease 2019 (COVID-19) in Wuhan, China, and found that patients with a cystatin C level of 0.80 mg/L or greater were at high risk of death. Therefore, cystatin C may have an important role in the prognosis of severe and critical patients with COVID-19.
Publish Date 2020-10-26 09:59
Citation Li Y, Yang S, Peng D, Zhu HM, Li BY, Yang X, Sun XL, Zhang M. Predictive value of serum cystatin C for risk of mortality in severe and critically ill patients with COVID-19. World J Clin Cases 2020; 8(20): 4726-4734
URL https://www.wjgnet.com/2307-8960/full/v8/i20/4726.htm
DOI https://dx.doi.org/10.12998/wjcc.v8.i20.4726
Full Article (PDF) WJCC-8-4726.pdf
Full Article (Word) WJCC-8-4726.docx
Manuscript File 57943-Review_WangTQ.doc
Answering Reviewers 57943-Answering reviewers.pdf
Audio Core Tip 57943-Audio core tip.m4a
Biostatistics Review Certificate 57943-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 57943-Conflict-of-interest statement.pdf
Copyright License Agreement 57943-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 57943-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 57943-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 57943-Language certificate.pdf
Peer-review Report 57943-Peer-review(s).pdf
Scientific Misconduct Check 57943-Scientific misconduct check.pdf
Scientific Editor Work List 57943-Scientific editor work list.pdf